Results 211 to 220 of about 434,628 (239)
Some of the next articles are maybe not open access.

CA 125 in gynecologic practice

American Journal of Obstetrics and Gynecology, 1986
Serum CA 125 levels were determined in 64 women with benign ovarian lesions, 92 women with uterine fundal lesions, and six patients who had negative second-look laparotomy for epithelial ovarian carcinoma. Of those with benign lesions, 13 of 31 patients with endometriosis had levels greater than 35 U/ml.
G D, Malkasian   +4 more
openaire   +2 more sources

CA-125 levels in endometriosis

Fertility and Sterility, 1986
CA-125 is a cellular antigen detected in many patients with ovarian cancer, but it has also been detected in patients with endometriosis. Preoperative CA-125 levels were drawn from 113 patients before they underwent laparoscopy. Patients were categorized into diagnostic groups on the basis of pathologic findings. CA-125 levels in patients with evidence
P E, Patton   +3 more
openaire   +2 more sources

CA-125 in gynecological malignancies

European Journal of Cancer and Clinical Oncology, 1987
CA-125 is an antigenic determinant that can be demonstrated in the majority of epithelial ovarian carcinomas. It can be measured in the serum with a radioimmunoassay by means of a monoclonal antibody. The tumor marker has a low specificity but high sensitivity for ovarian cancer, especially for serous cystadenocarcinoma.
W, Meier   +4 more
openaire   +2 more sources

CA 125 in the management of endometriosis

European Journal of Obstetrics & Gynecology and Reproductive Biology, 1993
CA 125 is expressed by eutopic and ectopic endometrium. In women with advanced endometriosis, plasma concentrations are increased towards the end of the luteal phase and during menstruation but not during the follicular and early luteal phases. In women without endometriosis, such cyclic changes of CA 125 in plasma are not observed.
P R, Koninckx   +3 more
openaire   +2 more sources

CA-125 and heart failure

International Journal of Cardiology, 2011

Ege, Meltem Refiker   +2 more
openaire   +4 more sources

CA-125 in Women with Endometriosis

Obstetrics and Gynecology Clinics of North America, 1989
The serum CA-125 level is elevated in most women with endometriosis. Although tests are readily available to measure the marker, simple modifications of the present assays are required to improve and standardize the quality of the measurements. The serum test has low sensitivity and would not be appropriate for general screening purposes, but in ...
openaire   +2 more sources

CA 125 in peritoneal washings and fluid: Correlation with plasma CA 125 and peritoneal cytology

International Journal of Gynecology & Obstetrics, 1989
Sixty-four women with ovarian cancer and 46 controls with benign gynecologic conditions underwent cytologic and CA 125 evaluations of peritoneal fluid or peritoneal washings at laparotomy. These parameters were correlated with preoperative disease status, intraoperative findings, and preoperative plasma CA 125 levels to determine their value in ...
P E, Schwartz   +4 more
openaire   +2 more sources

Spontaneous uroperitoneum and elevated Ca-125

European Journal of Internal Medicine, 2008
Spontaneous uroperitoneum occurs as a consequence of a traumatic rupture of the bladder (or ureters) leading to urinary ascites. Despite recognition of characteristic biochemical disturbances, the diagnosis remains problematic in cases without recognisable precipitating trauma.
Yu Xuan, Li, Ken, Vaux, Patrick, Coleman
openaire   +2 more sources

CA 125 in gynecological pathology — a review

European Journal of Obstetrics & Gynecology and Reproductive Biology, 1993
The original CA 125 serum tumor marker test is a homologous double-determinant (OC 125 monoclonal antibody based) assay for the quantification of tumor associated mucin-like CA 125 molecules present in the serum. Commercial kits, now supplied by various manufacturers (and in different versions, e.g.
P, Kenemans   +3 more
openaire   +2 more sources

CA 125 in Human Milk and Serum

Gynecologic and Obstetric Investigation, 2010
CA 125 serum concentrations drawn immediately following delivery exceeded 35 U/ml in all cases (median 276 U/ml). One week post partum elevations of CA 125 were still found, but the median level decreased to 45 U/ml. Six weeks after parturition no positivity was detected in the serum (median 12 U/ml).
L C, Fuith, G, Daxenbichler, C, Marth
openaire   +2 more sources

Home - About - Disclaimer - Privacy